Verano Preps Entry Into Major New Market Amid MSO Expansion Push
The Chicago-based MSO is readying infrastructure and capital for a significant geographic expansion as adult-use markets continue opening.

Street view showing 'Aur Ganic Coffee Shop' and a barber shop in Pattaya, Thailand.
Verano Signals Geographic Expansion Plans
Verano Holdings confirmed October 1 it's actively preparing to enter a significant new cannabis market, though the company didn't disclose which state or jurisdiction it's targeting. The announcement came during an industry briefing where the MSO outlined its near-term strategic priorities. Verano operates retail dispensaries and cultivation facilities across 13 states, with a concentration in Illinois, Pennsylvania, Florida, and Maryland.
The cleanest read on Verano's timing? Opportunistic. Adult-use cannabis sales launched in Ohio in August 2024, Delaware began retail operations in April 2025, and Minnesota is expected to open adult-use sales in early 2027. Verano already holds medical licenses in several states where adult-use programs are pending or recently launched.
Capital Allocation and Infrastructure Readiness
The MSO has been building cash reserves and preparing operational infrastructure to support rapid market entry once regulatory approval is secured. Verano reported $42.3 million in cash and cash equivalents as of its most recent quarterly filing, alongside $687 million in total revenue for the trailing twelve months ending June 30, 2026.
The company's expansion playbook typically involves:
- Acquiring or leasing cultivation and processing facilities before retail launch
- Securing retail licenses through competitive application processes or M&A
- Deploying proprietary brands including Verano, Savvy, and Encore across new markets
- Hiring local operational teams 6-12 months ahead of launch
Verano's approach contrasts with competitors like Curaleaf and Trulieve, which have favored bolt-on acquisitions of existing operators. Verano has historically preferred greenfield builds or distressed-asset purchases at steep discounts, avoiding the premium multiples that have burned other MSOs in recent years.
Competitive Landscape and Market Timing
Verano's expansion comes as MSOs face margin compression in mature markets like Illinois and Massachusetts, where wholesale flower prices have declined 40-60% since 2023. New markets offer higher margins during the first 18-24 months of adult-use sales, before supply catches up with demand. Ohio adult-use sales totaled $427 million in the first 12 months, according to state data. Maryland generated $236 million in the six months following its July 2023 launch.
Entering a market early allows MSOs to capture brand loyalty and retail footprint before competition saturates the space.
Verano's announcement follows similar expansion signals from Green Thumb Industries and Ayr Wellness, both of which have disclosed plans to enter Minnesota and have applied for licenses in states with pending adult-use programs. For full background on this story, see the CannIntel topic hub on Verano Market Expansion 2026.
What to Watch Next
The next signal will likely come from state regulatory filings or license-award announcements in the target jurisdiction. Verano hasn't disclosed whether it's pursuing licenses through competitive application, acquisition, or existing medical-to-adult-use conversion. Minnesota's Office of Cannabis Management is expected to award the first adult-use retail licenses in Q1 2027, while Delaware and Ohio continue processing new applications.
Investors will be watching Verano's Q3 2026 earnings call, expected in mid-November, for further clarity on capital deployment and market-entry timelines. The company's ability to execute without dilutive financing will depend on cash flow from existing operations and potential sale-leaseback transactions on owned real estate.
Frequently asked questions
Which state is Verano entering next?
Verano has not disclosed the target market. The most likely candidates are Minnesota, Delaware, or Ohio, all of which have recently launched or are preparing to launch adult-use cannabis sales. Verano already holds medical licenses in several states with pending adult-use programs.
How much cash does Verano have for expansion?
Verano reported $42.3 million in cash and cash equivalents as of June 30, 2026. The company generated $687 million in trailing twelve-month revenue, providing operational cash flow to support market entry without immediate need for dilutive equity raises.
Why are MSOs expanding into new markets now?
Mature cannabis markets like Illinois and Massachusetts have seen wholesale flower prices drop 40-60% since 2023, compressing margins. New adult-use markets offer significantly higher margins during the first 18-24 months of sales, before supply catches up with demand.
How does Verano's expansion strategy differ from competitors?
Verano typically pursues greenfield cultivation builds or acquires distressed assets at discounts, rather than paying premiums for established operators. This approach requires more upfront capital and longer timelines but avoids the goodwill impairments that have plagued MSO M&A deals.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Curaleaf Raises Aurora Cannabis Offer 25% to US$5 a Share
Curaleaf increased total implied consideration for Aurora to US$5 per share, an 86% premium to Aurora's unaffected price, sharpening a cross-border takeover contest.

MSO Money in Trump PACs May Fund Anti-Cannabis Senate Bid
MJBizDaily reports that millions in cannabis-company donations to Trump-aligned PACs may help bankroll a Senate candidate hostile to the industry.

MJBizDaily Reports MSO Trump Donors Now Back Anti-Cannabis Politician
A MJBizDaily report says multistate operators that gave millions to Donald Trump are also supporting an anti-cannabis politician, raising a return-on-spending question for the industry.
More from the newsroom

DEA Opens Schedule III Portal for Medical Cannabis Registrants
State-licensed medical cannabis manufacturers, distributors and labs can now seek Controlled Substances Act registration through Form 225, but key details remain undocumented.

NJCRC Suspends Magic Garden Botanicals Cultivation License
New Jersey's cannabis regulator suspended a cultivator's license at a special meeting. The grounds, duration and conditions are not yet in the public record we reviewed.

New York weighs disciplinary action against Claverack dispensary
The Daily Gazette reported Monday that state regulators are considering discipline for a Columbia County dispensary. The violations, penalty and licensee are not yet public.